Aventis Offers Plan To Protect Shareholders From Sanofi Plavix Patent Risk

The Aventis board also votes to enter into negotiations with Novartis, thereby satisfying one of Novartis’ two prerequisites for commencing merger talks. Aventis will “pursue discussions” with French and German authorities to address their concerns about an Aventis/Novartis deal.